enfortumab vedotin,pembrolizumab
merck,astellas,seagen
['bladder', 'urothelial', 'astellas', 'seagen', 'merck']
we re proud to announce with and merck that results from our clinical trial for first-line locally advanced/metastatic urothelial cancer will be presented as late-breaking data at #esmo22. learn about the significance of the findings for the #bladdercancer community.
Official Twitter for Seagen. Global biotechnology company focused on transformative cancer medicines to improve lives. Guidelines https://t.co/mK6wXiXw22